The goal of this observationnal study is to supplement the data collected in the pre-market study and confirm the rate of capsular ruptures due to Rx (reducing its related confidence interval).
During cataract surgery, an artificial lens is placed into the capsular bag. The main question this study aims to answer is :
Is Rx use associated with a rate of caspular ruptures lower than 2% ? Medical records of participants having cataract surgery with Rx laser as part of their regular medical care will be assessed in order to answer the study objective.
Adult patients (age > 18 years);
Diagnosed with cataract requiring surgery according to current guidelines;
Eligible to lens removal by phacoemulsification and replacement by a prosthetic lens under local anesthesia;
Who confirmed their non-opposition to data collection
Patient already operated with Rx for the first eye.
Any contra-indication to cataract surgery;
Patients with an ACD (Anterior Chamber Depth) less than 1.8mm and greater than 4.2mm;
Corneal disease or pathology that prevents corneal applanation or that may interfere with or hinder laser beam transmission;
Helix Surgical
Lead sponsor
Santé Atlantique - Saint-Herblain - France
Collaborator